Cargando…
Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study
(1) Background: Favipiravir (FVP) is a new antiviral drug used to treat COVID-19. It has been authorized to be used in the kingdom of Saudi Arabia in the treatment of COVID-19. The mechanism of action of FVP is working as a specific inhibitor for the RNA-dependent RNA polymerase of the RNA chain vir...
Autores principales: | Almutairi, Amal Oweid, El-Readi, Mahmoud Zaki, Althubiti, Mohammad, Alhindi, Yosra Zakariyya, Ayoub, Nahla, Alzahrani, Abdullah R., Al-Ghamdi, Saeed S., Eid, Safaa Yehia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966436/ https://www.ncbi.nlm.nih.gov/pubmed/36828545 http://dx.doi.org/10.3390/tropicalmed8020129 |
Ejemplares similares
-
Patterns of acute poisoning for children during outbreak of Corona virus in Makkah region Saudi Arabia
por: Althobaiti, Bashayer Mohammed, et al.
Publicado: (2023) -
The use of the nutritional supplements during the covid-19 outbreak in Saudi Arabia: A cross-sectional study
por: Hafiz, Nada Mohammed, et al.
Publicado: (2023) -
Overexpression of Inducible Nitric Oxide Synthase in Allergic and Nonallergic Nasal Polyp
por: Sadek, Ahmed Adel, et al.
Publicado: (2019) -
Fallopia japonica, a Natural Modulator, Can Overcome Multidrug Resistance in Cancer Cells
por: Eid, Safaa Yehia, et al.
Publicado: (2015) -
Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia
por: Alqurashi, Ghadi I., et al.
Publicado: (2023)